Enphys Acquisition Corp.
NFYS · NYSE
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.49 | -1.31 | -6.82 | -0.96 |
| FCF Yield | 0.30% | 0.43% | -1.45% | 1.03% |
| EV / EBITDA | -1,067.07 | 232.67 | 110.05 | -1,773.97 |
| Quality | ||||
| ROIC | 0.00% | -0.32% | -0.22% | -0.07% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.52 | 1.38 | -1.78 | 1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -28.96% | 121.00% | -176.70% | 99,819.94% |
| Safety | ||||
| Net Debt / EBITDA | -7.33 | 1.18 | 0.22 | 0.17 |
| Interest Coverage | 0.00 | -30.62 | -9.48 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |